Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Stanford University
Yale University
University of Maryland
Genentech
Information provided by (Responsible Party):
Lecia V. Sequist, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00977470
First received: September 11, 2009
Last updated: February 2, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)